Alector, Inc. (NASDAQ:ALEC – Free Report) – HC Wainwright issued their FY2026 earnings per share estimates for shares of Alector in a research report issued to clients and investors on Friday, November 6th. HC Wainwright analyst A. Ghosh forecasts that the company will post earnings per share of $0.80 for the year. HC Wainwright currently has a “Strong-Buy” rating on the stock. The consensus estimate for Alector’s current full-year earnings is ($0.55) per share. HC Wainwright also issued estimates for Alector’s Q4 2026 earnings at $0.12 EPS, Q1 2027 earnings at ($0.16) EPS, Q2 2027 earnings at ($0.17) EPS, Q3 2027 earnings at ($0.19) EPS, Q4 2027 earnings at ($0.19) EPS, FY2027 earnings at ($0.61) EPS, FY2028 earnings at ($0.58) EPS, FY2029 earnings at ($0.72) EPS and FY2030 earnings at ($0.52) EPS.
Other equities research analysts have also issued reports about the stock. UBS Group reiterated a “neutral” rating and set a $1.50 price target on shares of Alector in a research note on Tuesday, October 6th. Wall Street Zen upgraded shares of Alector from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings upgraded Alector from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, August 13th. Finally, Morgan Stanley lifted their target price on Alector from $2.00 to $3.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 6th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $4.62.
Check Out Our Latest Stock Report on Alector
Alector Trading Up 7.4%
Shares of Alector stock opened at $2.46 on Tuesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 5.26 and a current ratio of 5.26. The company has a fifty day simple moving average of $2.06 and a 200-day simple moving average of $2.04. Alector has a 12-month low of $1.09 and a 12-month high of $2.76.
Alector (NASDAQ:ALEC – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $1.11 earnings per share for the quarter, topping the consensus estimate of ($0.23) by $1.34. The business had revenue of $162.87 million during the quarter, compared to the consensus estimate of $2.19 million. Alector had a negative net margin of 850.13% and a negative return on equity of 531.03%.
Insider Activity
In related news, CFO Neil Berkley sold 29,251 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $2.66, for a total transaction of $77,807.66. Following the completion of the transaction, the chief financial officer directly owned 350,649 shares of the company’s stock, valued at $932,726.34. This represents a 7.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Arnon Rosenthal sold 72,606 shares of Alector stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $2.66, for a total value of $193,131.96. Following the completion of the sale, the chief executive officer owned 2,294,600 shares in the company, valued at approximately $6,103,636. This trade represents a 3.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 111,303 shares of company stock worth $295,633 in the last 90 days. 8.30% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Alector
A number of hedge funds and other institutional investors have recently bought and sold shares of ALEC. Russell Investments Group Ltd. boosted its position in shares of Alector by 8.2% during the 3rd quarter. Russell Investments Group Ltd. now owns 106,614 shares of the company’s stock worth $197,000 after purchasing an additional 8,118 shares in the last quarter. Nantahala Capital Management LLC purchased a new position in shares of Alector in the 2nd quarter valued at about $8,679,399. Public Employees Retirement System of Ohio purchased a new position in shares of Alector in the 2nd quarter valued at about $241,000. Bank of America Corp DE acquired a new stake in shares of Alector in the second quarter valued at about $287,000. Finally, Elmind Capital LP acquired a new stake in shares of Alector in the second quarter valued at about $1,809,000. Institutional investors and hedge funds own 85.83% of the company’s stock.
Alector News Summary
Here are the key news stories impacting Alector this week:
- Positive Sentiment: HC Wainwright forecasts EPS of $0.80 for FY2026, including $0.12 in Q4, versus the current full-year consensus estimate of a $0.55 loss. The firm’s Strong-Buy rating may bolster investor sentiment.
- Negative Sentiment: The analyst expects losses to resume: EPS forecasts are ($0.61) for FY2027, ($0.58) for FY2028, ($0.72) for FY2029, and ($0.52) for FY2030. These projections temper the near-term optimism.
About Alector
Alector, Inc (NASDAQ: ALEC) is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company’s research platform, known as immuno-neurology, is designed to use the body’s immune system to protect or restore the brain’s ability to maintain healthy neural connections.
Alector’s investigational pipeline has included antibody-based treatments for conditions such as frontotemporal dementia and Alzheimer’s disease. Its programs have targeted biological pathways associated with neurodegeneration, including progranulin and TREM2.
Read More
- Five stocks we like better than Alector
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Alector Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alector and related companies with MarketBeat.com's FREE daily email newsletter.
